Vagus nerve stimulation therapy in patients with autism spectrum disorder and intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry

Clinical article

Restricted access

Object

The purpose of this study was to determine the effectiveness of vagus nerve stimulation (VNS) therapy on quality-of-life (QOL) variables among patients with both autism spectrum disorder (ASD) and persistent or recurrent intractable epilepsy.

Methods

Data were obtained from the VNS therapy patient outcome registry, which was established after US FDA approval of the VNS device in 1997 as a means of capturing open-label clinical data outside of protocol. The integrity of the systems for collecting and processing registry data was authenticated by an independent auditing agency. The effect of potential selection bias, however, remains uncertain.

Results

Two cohorts were compared: 1) patients with epilepsy but without ASD (non-ASD [NASD] Group, 315 patients) who were being tracked in the registry (this cohort, which was controlled for age, included patients 20 years of age or younger); and 2) patients with a diagnosis of ASD who underwent implantation of the VNS device (ASD Group, 77 patients). Differences between the ASD and NASD groups were noted in the following categories: sex (male preponderance in ASD); normal imaging results (MR imaging results normal in ASD); depression (less common in ASD); behavioral problems (more common in ASD); neurological deficit (more common in ASD); mental retardation (more common in ASD); and developmental delay. The only QOL difference between the ASD and NASD groups was noted in mood at 12 months postimplant (mood was improved in ASD) (p = 0.04). There were no other differences in the QOL variables.

Conclusions

Patients with ASD and intractable epilepsy respond as favorably as all other patients receiving VNS therapy. In addition, they may experience a number of QOL improvements, some of which exceed those classically observed following placement of a VNS device.

Abbreviations used in this paper:AED = antiepileptic drug; ASD = autism spectrum disorder; NASD = non-ASD; QOL = quality of life; VNS = vagus nerve stimulation.
Article Information

Contributor Notes

Address correspondence to: Michael L. Levy, M.D., Ph.D., Division of Pediatric Neurosurgery, Rady Children's Hospital–San Diego, 8010 Frost Street, Suite 502, San Diego, California 92123. mlevy@chsd.org.

© AANS, except where prohibited by US copyright law.

Headings
References
  • 1

    Amar APApuzzo MLLiu CY: Vagus nerve stimulation therapy after failed cranial surgery for intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry. Neurosurgery 62:Suppl 25065132008

    • Search Google Scholar
    • Export Citation
  • 2

    Amar APHeck CNDeGiorgio CMApuzzo MLJ: Experience with vagus nerve stimulation for intractable epilepsy: some questions and answers. Neurol Med Chir (Tokyo) 39:4894951999

    • Search Google Scholar
    • Export Citation
  • 3

    Amar APHeck CNLevy MLSmith TDeGiorgio CMOviedo S: An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome. Neurosurgery 43:126512801998

    • Search Google Scholar
    • Export Citation
  • 4

    Amar APLevy MLMcComb JGApuzzo MLJ: Vagus nerve stimulation for control of intractable seizures in childhood. Pediatr Neurosurg 34:2182232001

    • Search Google Scholar
    • Export Citation
  • 5

    Danielsson SGillberg ICBillstedt EGillberg COlsson I: Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood. Epilepsia 46:9189232005

    • Search Google Scholar
    • Export Citation
  • 6

    Danielsson SViggedal GGillberg COlsson I: Lack of effects of vagus nerve stimulation on drug-resistant epilepsy in eight pediatric patients with autism spectrum disorders: a prospective 2-year follow-up study. Epilepsy Behav 12:2983042008

    • Search Google Scholar
    • Export Citation
  • 7

    Deonna TRoulet E: Autistic spectrum disorder: evaluating a possible contributing or causal role of epilepsy. Epilepsia 47:Suppl 279822006

    • Search Google Scholar
    • Export Citation
  • 8

    Derry PAWiebe S: Psychological adjustment to success and to failure following epilepsy surgery. Can J Neurol Sci 27:Suppl 1S116S1252000

    • Search Google Scholar
    • Export Citation
  • 9

    Fisher RSHandforth A: Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 53:6666691999

    • Search Google Scholar
    • Export Citation
  • 10

    Frost MGates JHelmers SLWheless JWLevisohn PTardo C: Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia 42:114811522001

    • Search Google Scholar
    • Export Citation
  • 11

    Helmers SLWheless JWFrost MGates JLevisohn PTardo C: Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study. J Child Neurol 16:8438482001

    • Search Google Scholar
    • Export Citation
  • 12

    Kirchberger KHummel CStefan H: Postoperative multichannel magnetoencephalography in patients with recurrent seizures after epilepsy surgery. Acta Neurol Scand 98:171998

    • Search Google Scholar
    • Export Citation
  • 13

    Ko DHeck CGrafton SApuzzo MLJCouldwell WTChen T: Vagus nerve stimulation activates central nervous system structures in epileptic patients during PET H2(15)O blood flow imaging. Neurosurgery 39:4264311996

    • Search Google Scholar
    • Export Citation
  • 14

    Lang TASecic M: How to Report Statistics in Medicine: Annotated Guidelines for Authors Editors and Reviewers PhiladelphiaAmerican College of Physicians1997

    • Search Google Scholar
    • Export Citation
  • 15

    Levisohn PM: The autism-epilepsy connection. Epilepsia 48:Suppl 933352007

  • 16

    Morris GL IIIMueller WM: Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01–05. Neurology 53:173117351999. [Erratum in Neurology 54:1712 2000]

    • Search Google Scholar
    • Export Citation
  • 17

    Munari CBerta ETassi LLo Russo GCardinale FFrancione S: Analysis of failures and reoperations in resective epilepsy surgery. Adv Neurol 84:6056142000

    • Search Google Scholar
    • Export Citation
  • 18

    Murphy JVWheless JWSchmoll CM: Left vagal nerve stimulation in six patients with hypothalamic hamartomas. Pediatr Neurol 23:1671682000

    • Search Google Scholar
    • Export Citation
  • 19

    National Institute of Mental Health: What are the autism spectrum disorders? (http://www.nimh.nih.gov/health/publications/autism/complete-index.shtml#pub2) [Accessed March 17 2010]

    • Search Google Scholar
    • Export Citation
  • 20

    Park YD: The effects of vagus nerve stimulation therapy on patients with intractable seizures and either Landau-Kleffner syndrome or autism. Epilepsy Behav 4:2862902003

    • Search Google Scholar
    • Export Citation
  • 21

    Saemundsen ELudvigsson PRafnsson V: Autism spectrum disorders in children with a history of infantile spasms: a population-based study. J Child Neurol 22:110211072007

    • Search Google Scholar
    • Export Citation
  • 22

    Schachter SCSaper CB: Vagus nerve stimulation. Epilepsia 39:6776861998

  • 23

    Spencer SS: Long-term outcome after epilepsy surgery. Epilepsia 37:8078131996

  • 24

    Warwick TCGriffith JReyes BLegesse BEvans M: Effects of vagus nerve stimulation in a patient with temporal lobe epilepsy and Asperger syndrome: case report and review of the literature. Epilepsy Behav 10:3443472007

    • Search Google Scholar
    • Export Citation
  • 25

    Wiebe SDerry PA: Measuring quality of life in epilepsy surgery patients. Can J Neurol Sci 27:Suppl 1S111S1252000

TrendMD
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 577 576 55
Full Text Views 88 65 1
PDF Downloads 155 84 0
EPUB Downloads 0 0 0
PubMed
Google Scholar